These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fever after immunization: current concepts and improved future scientific understanding. Kohl KS; Marcy SM; Blum M; Connell Jones M; Dagan R; Hansen J; Nalin D; Rothstein E; Clin Infect Dis; 2004 Aug; 39(3):389-94. PubMed ID: 15307007 [TBL] [Abstract][Full Text] [Related]
3. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B; Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547 [TBL] [Abstract][Full Text] [Related]
4. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization. Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456 [TBL] [Abstract][Full Text] [Related]
5. Risk of serious neurologic disease after immunization of young children in Britain and Ireland. Ward KN; Bryant NJ; Andrews NJ; Bowley JS; Ohrling A; Verity CM; Ross EM; Miller E Pediatrics; 2007 Aug; 120(2):314-21. PubMed ID: 17671057 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068 [TBL] [Abstract][Full Text] [Related]
7. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220 [TBL] [Abstract][Full Text] [Related]
8. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule? Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770 [TBL] [Abstract][Full Text] [Related]
9. Multiple vaccinations and the risk of medically attended fever. Lin ND; Kleinman K; Chan KA; Soumerai S; Mehta J; Mullooly JP; Shay DK; Kolczak M; Lieu TA; Vaccine; 2010 Jun; 28(25):4169-74. PubMed ID: 20409495 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973 [TBL] [Abstract][Full Text] [Related]
11. The impact of DTaP-IPV-HB vaccine on use of health services for young infants. Thompson LA; Irigoyen M; Matiz LA; LaRussa PS; Chen S; Chimkin F Pediatr Infect Dis J; 2006 Sep; 25(9):826-31. PubMed ID: 16940842 [TBL] [Abstract][Full Text] [Related]
12. Acetaminophen and ibuprofen for prevention of adverse reactions associated with childhood immunization. Manley J; Taddio A Ann Pharmacother; 2007 Jul; 41(7):1227-32. PubMed ID: 17519301 [TBL] [Abstract][Full Text] [Related]
13. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related]
14. How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine? Halperin SA; Sweet L; Baxendale D; Neatby A; Rykers P; Smith B; Zelman M; Maus D; Lavigne P; Decker MD Pediatr Infect Dis J; 2006 Mar; 25(3):195-200. PubMed ID: 16511379 [TBL] [Abstract][Full Text] [Related]
16. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands. David S; Vermeer-de Bondt PE; van der Maas NA Vaccine; 2008 Oct; 26(46):5883-7. PubMed ID: 18775463 [TBL] [Abstract][Full Text] [Related]
17. Viscerotropic disease following yellow fever vaccination in Peru. Whittembury A; Ramirez G; Hernández H; Ropero AM; Waterman S; Ticona M; Brinton M; Uchuya J; Gershman M; Toledo W; Staples E; Campos C; Martínez M; Chang GJ; Cabezas C; Lanciotti R; Zaki S; Montgomery JM; Monath T; Hayes E Vaccine; 2009 Oct; 27(43):5974-81. PubMed ID: 19679215 [TBL] [Abstract][Full Text] [Related]
18. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations]. Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376 [TBL] [Abstract][Full Text] [Related]
19. An algorithm developed using the Brighton Collaboration case definitions is more efficient for determining diagnostic certainty. Joshi D; Alsentzer E; Edwards K; Norton A; Williams SE Vaccine; 2014 Jun; 32(28):3469-72. PubMed ID: 24795227 [TBL] [Abstract][Full Text] [Related]
20. Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005. Fernandes GC; Camacho LA; Sá Carvalho M; Batista M; de Almeida SM Vaccine; 2007 Apr; 25(16):3124-8. PubMed ID: 17316927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]